| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 13, 2007
Accepted on August 21, 2007
Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, P.O. Box 12233, 111 TW Alexander Drive, RTP, NC-27709
* To whom correspondence should be addressed. E-mail: wadep2{at}niehs.nih.gov.
The estrogen receptor-alpha (ER-
, ESR1) is a key regulatory molecule in mammary epithelial cell development. Loss of ER-
in breast cancer is correlated with poor prognosis, increased recurrence following treatment, and an elevated incidence of metastasis. A proposed molecular pathway by which ER-
acts to constrain invasive growth in breast cancer cells involves direct, ER-
dependent expression of MTA3, a cell-type specific component of the Mi-2/NuRD chromatin remodeling complex. MTA3 in turn represses expression of Snail, a transcription factor linked to epithelial to mesenchymal transition (EMT) and cancer metastasis. To elucidate its role(s) in EMT, we expressed Snail in the non-invasive, ER-
positive MCF-7 cell line. Snail expression led to decreased cell-cell adhesion and increased cell invasiveness. Further, we observed loss of ER-
expression at both the RNA and protein level that was accompanied by direct interaction of Snail with regulatory DNA sequences at the ESR1 locus. A consequence of loss of ER-
function in this system was the increased abundance of key components of the transforming growth factor-
(TGF-
) signaling pathway. Thus, cross-talk between ER-
, Snail and the TGF-
pathway appears to control critical phenotypic properties of breast cancer cells.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
N. Dumont, M. B. Wilson, Y. G. Crawford, P. A. Reynolds, M. Sigaroudinia, and T. D. Tlsty Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers PNAS, September 30, 2008; 105(39): 14867 - 14872. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |